SEC 13F Intelligence

Highline Capital Management, L.P. / MRNA

Highline Capital Management, L.P.’s Moderna Inc Position

Does Highline Capital Management, L.P. own Moderna Inc (MRNA)? Not currently — the last reported position was 250.0K shares worth $7M in Q1 2020; the fund’s latest 13F (Q4 2022) no longer reports it.

Position Value
$7M
Q1 2020
Shares
250.0K
% of Portfolio
+1.82%
Quarters Held
3
position exited

Position History MRNA

Reported value by quarter
Q1 ’19: $19MQ1 ’19Q4 ’19: $3MQ4 ’19Q1 ’20: $7MQ1 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2020250.0K$7M+1.82%
Q4 2019150.0K$3M+0.46%
Q1 2019930.2K$19M+1.19%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highline Capital Management, L.P.’s full portfolio or all institutional holders of MRNA.